CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.
Urethritis - male - Management
Basis for recommendation
These recommendations are based on expert opinion from a UK National Guideline on the Management of non-gonococcal urethritis (NGU), published by the British Association for Sexual Health and HIV [BASHH, 2007], a European guideline [Shahmanesh et al, 2009], and a Canadian guideline [Public Health Agency of Canada, 2008].
Persistent/recurrent urethritis
- Persistent or recurrent urethritis occurs in 10–20% of men following treatment and the cause is complex and poorly understood. Although persistent Mycoplasma genitalium infection has been identified (in 20–40% of men with persistent/recurrent urethritis) and Ureaplasma urealyticum has also been implicated, in most men no infection is detected.
- Establishing an accurate diagnosis of ongoing urethritis is central to management and can usually only be undertaken by a trained specialist. Therefore, CKS strongly advises referral for all men with persistent or recurrent urethritis.
© NHS Institute for Innovation and Improvement